Healthcare leaders will discuss how artificial intelligence tools are enhancing clinical documentation, reducing payer denials, and improving patient outcomes
SEATTLE and HUNTINGTON BEACH, Calif., Oct. 29, 2024 /PRNewswire-PRWeb/ -- MCG Health, part of the Hearst Health network and an industry leader in technology-enabled, evidence-based guidance, announces its Director of Product Management, Marivie Lanter, MBA, RN, BSN, and Anthony N. Akosa, MD, MBA, the Corporate Vice President of Care Management at Franciscan Alliance, will be featured speakers at the upcoming ACMA Leadership and Physician Advisor Conference (LPAC). This premier industry event for clinical leaders in case management, physician advisors, medical directors/CMOs, CNOs, and healthcare administrators, will be held November 18-20, 2024, in Huntington Beach, California.
Ms. Lanter and Dr. Akosa are set to deliver a compelling speaking session, "Harnessing the Power of Patient Data: Enhancing UM Performance, Mitigating Unnecessary Denials, and Improving Outcomes" on Wednesday, November 20, from 7:15 am – 8:15 am PT. Their session will explore how artificial intelligence technologies can help support timely and accurate clinical documentation and mitigate unnecessary denials from payers. In addition, the speakers will examine how utilization management, case management, and physician advisor teams can surface patient-specific data within the hospital EHR (electronic health record) and automatically compare it to nationally recognized, evidence-based guidelines to support clinical decisions.
Key objectives of the session will include:
- Assessing strategies to improve observation rates, mitigate denials, enhance payer-provider collaboration, reduce chart review time, and prevent staff burnout
- Evaluating how optimizing documentation practices can support better patient outcomes
"I am thrilled to be co-presenting with the eminent physician leader, Dr. Anthony Akosa, from Franciscan Alliance at the 2024 ACMA Leadership and Physician Advisor Conference," said Ms. Lanter. "Our session qualifies for continuing education credit and will focus on the importance of using evidence-based guidelines - in combination with AI technology - to enhance clinical decision-making. This approach is particularly significant for healthcare leaders when they consider compliance with new legislation such as California's recent SB 1120 which requires a human being to be involved in the final decision. Dr. Akosa and I will demonstrate the importance of basing care management decisions on independently developed guidelines that can be surfaced and referenced by AI tools rather than just machine learning algorithms alone."
For more information about the session and to register for the ACMA Leadership & Physician Advisor conference, visit https://events.acmaweb.org/website/63446/home/.
About MCG Health
MCG, part of the Hearst Health network, provides unbiased clinical guidance that gives healthcare organizations confidence in delivering patient-centered care. MCG's artificial intelligence and technology, infused with clinical expertise, enable its clients to prioritize and simplify their work. MCG's world-class customer service ensures that clients maximize the benefits of licensing MCG solutions – demonstrating improved clinical and financial outcomes. For more information visit http://www.mcg.com.
About Hearst Health
The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person's health journey. Care guidance from Hearst Health reaches the majority of people in the U.S. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase, MHK and QGenda. Hearst also holds a minority interest in the precision medicine and oncology analytics company Aster Insights. Follow Hearst Health on X @HearstHealth and LinkedIn @Hearst-Health.
Media Contact
Arri Stewart, MCG Health, (206) 389-5405, [email protected], https://www.mcg.com/
SOURCE MCG Health
Share this article